Akero Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious metabolic diseases. The company's initial focus is on nonalcoholic steatohepatitis ("NASH"), a disease without any approved therapies. NASH is a severe form of nonalcoholic fatty liver disease ("NAFLD"), characterized by inflammation and fibrosis in the liver that can progress to cirrhosis, failure, cancer of the liver, and death. The company is developing AKR-001, an analog of fibroblast growth factor 21 ("FGF21"), for NASH and plan to initiate a Phase 2a clinical trial for AKR-001 in NASH patients with fibrosis in the middle of 2019.

Apellis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on treating disease through the inhibition of the complement system, which is a component of the immune system, at the level of C3, the central protein in the complement cascade. The company's clinical program targets C3 with Phase 3 clinical trials of its main product candidate, APL-2, in multiple indications. APL-2 has the potential to be a treatment that address the limitations of existing treatment options or provide a treatment option. The company is also conducting a Phase 2 trial of APL-2 in glomerular diseases, including C3 glomerulopathy, IgA nephropathy, primary membranous nephropathy and lupus nephritis.

Arlo Technologies combines an intelligent cloud infrastructure and mobile app with a variety of smart connected devices. The company's cloud-based platform provides users with visibility, insight and a solution to help protect and connect in real-time with the people and things from any location with a Wi-Fi or a cellular connection. The company's smart connected devices include Arlo Security Camera, Arlo Q and Arlo Q Plus, Arlo Pro, Arlo Go, Arlo Baby, Arlo Pro 2, Arlo Audio Doorbell, Arlo Chime, Arlo Ultra, Arlo Pro 3 and Arlo Video Doorbell. The company's Arlo accessories include Arlo Charging Accessories, Arlo Mounts and Arlo Skins.

Banca Profilo SpA is an Italy-based bank engaged in the provision of private banking services and financial services. The Bank structures its business into fours sectors: Private Banking sector, which offers services for private and institutional clients, including asset management, investment banking and fiduciary services; Finance sector, which consists of management and development of financial instruments trading activity in own account and for third parties; Foreign Activity sector, which comprises the Bank's activities in Switzerland, including the provision of private banking services, wealth management and securities brokerage, and Corporate Centre sector, which is active in the coordination, control and management of the Bank and its subsidiaries. The Company operates through consolidated subsidiaries, such as Profilo Real Estate Srl, Banque Profil de Gestion Sa and Arepo Fiduciaria Srl.

BJ's Restaurants operates in the casual dining segment of the restaurant industry. The company's restaurants feature a number of menu offerings including: slow roasted entrees, such as, prime rib; EnLIGHTened Entrees? such as its Cherry Chipotle Glazed Salmon; its deep-dish pizza; the Pizookie? dessert; and its BJ's proprietary craft beers. The company owns and operates restaurants located in various states, and its proprietary craft beer is produced at various locations, its Temple, TX brewpub locations and by independent third party brewers using its proprietary recipes. The company also produces its proprietary non-alcoholic craft sodas including root beer, ginger beer, cream, orange and black cherry soda.

Community Health Systems is a holding company. Through its subsidiaries, the company operates general acute care hospitals and outpatient facilities. The company provides healthcare services through the hospitals that it owns and operates and affiliated businesses in non-urban and selected urban markets. Services provided through the company's hospitals and affiliated businesses include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric and rehabilitation services. The company also provides additional outpatient services at urgent care centers, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers.

HCA Healthcare is a holding company. Through its subsidiaries, partnerships and joint ventures, the company owns and operates hospitals and related health care entities. Most of the company's general, acute care hospitals provide medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services and emergency services. The general, acute care hospitals also provide outpatient services such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology and physical therapy. The company's psychiatric hospitals provide therapeutic programs including child, adolescent and adult psychiatric care, adolescent and adult alcohol and drug abuse treatment and counseling.

Iridium Communications is a provider of mobile voice and data communications services to businesses, the U.S. and foreign governments, non-governmental organizations and consumers. The company's Commercial Services include Postpaid Mobile Voice and Data Satellite Communications, Iridium push-to-talk, Broadband Data, and Internet of Things (IoT) Services. The company provides U.S. government customers bulk access to its services, including voice, netted voice, data, messaging and paging services. The company's products include Satellite Handsets, Iridium GO!, Voice and Data Modems, Broadband Data Devices, IoT Data Devices, and Device Development and Manufacturing.

Park City Group is a Software-as-a-Service provider. Through its subsidiary, ReposiTrak Inc., the company operates a business-to-business e-commerce, compliance, and supply chain management platform that partners with retailers, wholesalers, and product suppliers. The company's solutions and services are: ReposiTrak MarketPlace, which enables its customers to screen and choose suppliers based on a various criteria; ReposiTrak Compliance and Food Safety solutions, which help its customers reduce potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions, which enable its customers to sell products from Direct Store Delivery suppliers on a consignment basis.

Procter & Gamble provides consumer packaged goods. The company's products are sold primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, baby stores, beauty stores, other stores and pharmacies. The company has five reportable segments: Beauty, which includes hair care, and skin and personal care products; Grooming, which includes shave care products; Health Care, which includes oral care and personal health care products; Fabric and Home Care, which includes fabric care and home care products; and Baby, Feminine and Family Care, which includes baby care, feminine care and family care products.

Schrodinger is transforming the way therapeutics and materials are discovered. The company sells its software solutions to biopharmaceutical and industrial companies, academic institutions, and government laboratories. The company also applies its computational platform to a broad pipeline of drug discovery programs in collaboration with biopharmaceutical companies. The company operations through two segments: Software and Drug Discovery.

ShockWave Medical is a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. The company serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors.

Surgery Partners is a holding company. Through its subsidiaries, the company is a healthcare services company. The company operates in three reporting segments : Surgical Facility Services, which consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals; Ancillary Services, which consists of a diagnostic laboratory and multi-specialty physician practices; and Optical Services, which consists of an optical laboratory and an optical products group purchasing organization. As of Dec 31 2017, the company owned or operated primarily in partnership with physicians, a portfolio of 124 surgical facilities comprised of 106 ASCs and 18 surgical hospitals across 32 states.

Tenet Healthcare is a healthcare services company. Through its subsidiaries, partnerships and joint ventures, including USPI Holding Company, Inc., the company operates hospitals, surgical hospitals and outpatient centers. In addition, the company's Conifer Holdings, Inc. (Conifer) subsidiary provides healthcare business process services in the areas of hospital and physician revenue cycle management and care solutions to healthcare systems, as well as individual hospitals, physician practices, self-insured organizations, health plans and other entities. The company has three reportable segments: Hospital Operations and other; Ambulatory Care; and Conifer.

UFP Technologies is a designer and custom manufacturer of components, subassemblies, products and packaging utilizing foams, films, and plastics primarily for the medical market. The company's single-use and single-patient devices and components are used in a range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging. The company also provides engineered products and components to customers in the automotive, aerospace and defense, consumer, electronics and industrial markets such as military uniform and gear components, automotive interior trim, and protective packaging, among other.

Viking Therapeutics is a biopharmaceutical company focused on the development of therapies for metabolic and endocrine disorders. The company's main clinical program's drug candidate, VK2809, is an orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta in development for patients with non-alcoholic fatty liver disease and elevated low-density lipoprotein cholesterol. The company's second clinical program's primary drug candidate, VK5211, is an orally available, non-steroidal selective androgen receptor modulator in development for patients recovering from non-elective hip fracture surgery. The company is also developing VK0214 for X-linked adrenoleukodystrophy.

WD-40 is engaged in developing and selling products that solve problems in workshops, factories and homes. The company markets its maintenance products and its homecare and cleaning products under the following brands: WD-40?, 3-IN-ONE?, GT85?, X-14?, 2000 Flushes?, Carpet Fresh?, no vac?, Spot Shot?, 1001?, Lava? and Solvol?. The WD-40 brand includes the WD-40 Multi-Use Product and the WD-40 Specialist? and WD-40 BIKE? product lines. The company's brands are sold in various locations. Maintenance products are sold in markets in North, Central and South America, Asia, Australia, Europe, the Middle East and Africa. Homecare and cleaning products are sold in North America, the United Kingdom and Australia.